Methyl 6-cyano-4-oxo-1,4-dihydroquinoline-2-carboxylate

Catalog No. :
ACPAUL687
CAS No. :
1078130-59-2
Molecular Formula :
C12H8N2O3
Molecular Weight :
228.21

IUPAC Name:methyl 6-cyano-4-oxo-1,4-dihydroquinoline-2-carboxylate

Methyl 6-cyano-4-oxo-1,4-dihydroquinoline-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$234.00Login to see priceInquiryInquiry
1g97%$535.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 6-cyano-4-oxo-1,4-dihydroquinoline-2-carboxylate
IUPAC Namemethyl 6-cyano-4-oxo-1,4-dihydroquinoline-2-carboxylate
MDL No.MFCD20040064
Molecular FormulaC12H8N2O3
Molecular Weight228.21
SMILESO=C(C(NC1=C2C=C(C#N)C=C1)=CC2=O)OC
InChI KeyHWPAIPTYSWLOCZ-UHFFFAOYSA-N
Synonym6-Cyano-4-oxo-1,4-dihydro-quinoline-2-carboxylic acid Methyl ester;2-Quinolinecarboxylic acid, 6-cyano-1,4-dihydro-4-oxo-, methyl ester;Methyl 6-cyano-4-oxo-1,4-dihydroquinoline-2-carboxylate
CAS No.1078130-59-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPAUL687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXIKW218 route compound structure diagram
    ACXIKW218262586-62-9 In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACPAUL687 route product structure diagram
    ACPAUL6871078130-59-2
Inquiry

2. ACPAUL687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXIKW218 route compound structure diagram
    ACXIKW218262586-62-9 In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACPAUL687 route product structure diagram
    ACPAUL6871078130-59-2
Inquiry

Comments (0)